Editas Medicine, Inc. Common Stock (EDIT) is a publicly traded Healthcare sector company. As of May 20, 2026, EDIT trades at $2.57 with a market cap of $247.70M and a P/E ratio of -2.19. EDIT moved +6.10% today. Year to date, EDIT is +30.65%; over the trailing twelve months it is +58.54%. Its 52-week range spans $0.91 to $4.54. Analyst consensus is buy with an average price target of $6.60. Rallies surfaces EDIT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
EDIT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EDIT recently traded at $2.57. Market cap is $247.70M. P/E ratio is -2.19. Revenue is $38.69M.
| Metric | Value |
|---|---|
| Price | $2.57 |
| Market Cap | $247.70M |
| P/E Ratio | -2.19 |
| EPS | $-1.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.54 |
| 52-Week Low | $0.91 |
| Volume | 1.21M |
| Avg Volume | 0 |
| Revenue (TTM) | $38.69M |
| Net Income | $-108.95M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $40.52M | $-160.06M | $-1.80 |
| 2024 | $32.31M | $-237.09M | $-2.88 |
| 2023 | $78.12M | $-153.22M | $-2.02 |
| 2022 | $19.71M | $-220.43M | $-3.21 |
10 analysts cover EDIT: 0 strong buy, 5 buy, 3 hold, 2 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.60.